+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Sjogren's syndrome Market Research and Forecast 2018-2023

  • ID: 4700789
  • Report
  • October 2018
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now


  • Allergan Inc
  • Astellas Pharma Inc.
  • Biogen
  • Cinkate Corp.
  • Eisai
  • Genentech, Inc.,
  • MORE
The Sjogren’s syndrome is chronic autoimmune disease, in which the moisture-producing gland of the body is affected. It may be caused due to genetics, environmental changes or due to exposure to viruses or bacteria, which may result in primary or secondary Sjogren’s syndrome. The symptoms of this disease include Xerostomia (dry mouth), keratoconjunctivitis sicca (dry eye), skin dryness may result in lymphocytic infiltration and affects organs such as lungs, kidney, blood vessel and brain. According to American Sjogren’s syndrome association, about 70 % of patients results in positive anti-nuclear antibody test whereas 60-70% patients have positive rheumatoid (RF). The Sjogren’s syndrome majorly affects between the age of 40s and females are largely affected with Sjogren’s syndrome in comparison to males.

The Sjogren’s syndrome treatment and diagnosis market growth is driven by the development of advanced techniques. Various tests aid in the diagnosis of Sjogren’s syndrome. The adoption towards newer diagnostic techniques encourages higher diagnosis of disease. However, lack of awareness of Sjogren’s syndrome among people is one of the factors inhibiting the growth of Sjogren’s syndrome treatment market. The improvised awareness among people enables in providing a platform for the opportunity to enhance in future Sjogren’s syndrome market.

The global Sjogren’s syndrome market is analyzed on the basis of geographical regions which are contributing significantly towards the growth of the market. North America and Europe hold strong share in global Sjogren syndrome market. Due to growing Sjogren’s syndrome and adoption of various techniques enables in driving the market. The Asia Pacific region is forecasted to exhibit rapid growth of Sjogren’s syndrome market due to rising awareness among people relating to Sjogren’s syndrome.

The companies contributing in global market includes Allergen Inc., Amgen, Auven Therapeutics, Pfizer, Novartis, and Santen Pharmaceutical Co. Ltd. The companies are focusing to provide products and technologies for providing a diagnosis of Sjogren’s syndrome, which is fueling the global market. The companies provide competitive landscape by competing, the factors include price, quality, innovation, reputation, and distribution. The companies enter in strategic collaboration and partnership for boosting up the standard of the market.

The Sjogren’s syndrome market is segmented on the basis of the test, syndrome type, application, drug type and end users. The market segment for Sjogren’s syndrome by test, syndrome type, application, drug type and end user include erythrocyte sedimentation rate, musculoskeletal, imaging, cortisone and others. The advancement of technology and awareness regarding health concerns increases the demand for Sjogren’s syndrome market globally.

Research methodology

The market study of Global Sjogren ‘s syndrome treatment and diagnosis market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Authentic Public Databases such as the FDA, WHO and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue.
The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating in delivering insights into the market for better business decisions.

Market Segmentation:
  • Global Sjogren‘s Syndrome Treatment and Diagnosis market is segmented on the basis of regional outlook and following segments:
  • Sjogren‘s Syndrome Treatment and Diagnosis Market Research and Analysis, by Test
  • Sjogren‘s Syndrome Treatment and Diagnosis Market Research and Analysis, by syndrome type
  • Sjogren‘s Syndrome Treatment and Diagnosis Market Research and Analysis, by application
  • Sjogren‘s Syndrome Treatment and Diagnosis Market Research and Analysis, by drug type
  • Sjogren‘s Syndrome Treatment and Diagnosis Market Research and Analysis, by end users
The Report Covers::
  • Comprehensive research methodology of Sjogren‘s Syndrome Treatment and Diagnosis market.
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Sjogren‘s Syndrome Treatment and Diagnosis Market.
  • Insights about market determinants which are stimulating the Sjogren‘s Syndrome Treatment and Diagnosis
  • Detailed and extensive market segments with regional distribution of forecasted revenues
  • Broad profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3


  • Allergan Inc
  • Astellas Pharma Inc.
  • Biogen
  • Cinkate Corp.
  • Eisai
  • Genentech, Inc.,
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World

3. Market Determinant
3.1. Motivators
3.1.1. Increasing Number of Sjogren’s Syndrome Patients
3.1.2. R&D Activities for Sjogren’s Syndrome
3.1.3. Government Initiatives
3.2. Restraints
3.2.1. Lack of Awareness about Sjogren’s Syndrome
3.3. Opportunities
3.3.1. Pre-Diagnosis of Sjogren’s Syndrome
3.3.2. Improvised Awareness Among Patients

4. Market Segmentation
4.1. Global Sjogren’s Syndrome Market, By Test
4.1.1. On Basis of Blood Test Erythrocyte Sedimentation Rate (ESR) Immunoglobulins (IGs) Rheumatoid Factor (RF) Anti-Nuclear Antibody (ANA)
4.1.2. On Basis of Eye Test Schirmer’s Tear Test Slit Lamp Test Rose Bengal Test
4.1.3. On Basis of Imaging Test Sialogram Salivary Scintigraphy
4.1.4. Biopsy
4.2. By Syndrome Type
4.2.1. Primary Sjogren Syndrome
4.2.2. Secondary Sjogren Syndrome
4.3. By Application
4.3.1. Eye Care
4.3.2. Vaginal Dryness
4.3.3. Musculoskeletal
4.3.4. Systemic
4.3.5. Dental Care
4.4. Global Sjogren Syndrome Market by Drugs Type
4.4.1. Pilocarpine
4.4.2. Cyclosporine
4.4.3. Hydroxychloroquine
4.4.4. Immunosuppressive Agents
  • Azathioprine
  • Cortisone
  • Cyclophosphamide
4.5. Global Sjogren’s syndrome market by end users
4.5.1. Hospitals
4.5.2. Clinical Laboratories
4.5.3. Pharmacies

5. Competitive Landscape
5.1. Key Market Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.1.3. Rest of North America
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest of the world

7. Company profiles
7.1. Allergan Inc
7.2. Amgen
7.3. arGentis Pharmaceuticals, LLC
7.4. Astellas Pharma Inc.
7.5. AstraZeneca
7.6. Biogen
7.7. Bristol-Myers Squibb
7.8. Cinkate Corp.
7.9. Daiichi Sankyo
7.10. Eisai
7.11. Genentech, Inc.,
7.12. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd,
7.13. Kissei Pharmaceutical Co., Ltd.
7.14. MedImmune, LLC
7.15. Nicox S.A
7.16. Novartis International AG
7.17. Otsuka Pharmaceutical Co. Ltd
7.18. Ono Pharmaceutical
7.19. Pfizer Inc.
7.20. F. Hoffmann-La Roche AG
7.21. Santen Pharmaceutical Co. Ltd
7.22. Sanofi S.A.
Note: Product cover images may vary from those shown
3 of 3
  • Allergan Inc
  • Amgen
  • Argentis Pharmaceuticals, Llc
  • Astellas Pharma Inc.
  • Astrazeneca
  • Biogen
  • Bristol-Myers Squibb
  • Cinkate Corp.
  • Daiichi Sankyo
  • Eisai
  • Genentech, Inc.,
  • Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd,
  • Kissei Pharmaceutical Co., Ltd.
  • Medimmune, Llc
  • Nicox S.A
  • Novartis International Ag
  • Otsuka Pharmaceutical Co. Ltd
  • ONO Pharmaceutical
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ag
  • Santen Pharmaceutical Co. Ltd
  • Sanofi S.A.
Note: Product cover images may vary from those shown